ASX:VLSPharmaceuticals
Vita Life Sciences (ASX:VLS) Shares Reflect A Stronger Margin Story
Vita Life Sciences stock barely flinched after the half year 2026 numbers, even though the business just printed another solid step up in earnings power. The market left the shares around A$2.60, while the trailing price to earnings multiple sits near 12.7x and the dividend yield around 5.38%. The key development in this healthcare group is a cleaner earnings engine. Net profit margin on a trailing basis is 11.6% and higher than a year ago, which frames this result as a quiet but important...